Sujatha Rao, MD
Hematology-Oncology · Carbondale, ILNPI 1356420368
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $620 of the $933 with a category attached, or 66.5%. It is spread thinly across 16 manufacturers, the largest accounting for just 23.5%. Reporting peaked in 2019 at $420 and has fallen 70.7% since, to $123 in 2025.
Across 41 payments — averaging $22.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$220
- Astellas Pharma US Inc$148
- Sanofi-aventis U.S. LLC$100
- Novartis$98
- Incyte Corporation$93
- Bristol Myers Squibb$54
- plus $220 from 10 others
What the payments were for
- Food & beverage$62066%
- Education$31334%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 12 | $220 |
| Astellas Pharma US Inc | 5 | $148 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Novartis | 6 | $98 |
| Incyte Corporation | 2 | $93 |
| Bristol Myers Squibb | 3 | $54 |
| Pfizer | 3 | $37 |
| Jazz Pharmaceuticals Inc. | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Bayer | 1 | $25 |
| Agios Pharmaceuticals, Inc. | 1 | $21 |
| Servier Pharmaceuticals LLC | 1 | $21 |
| Mirati Therapeutics, Inc. | 1 | $17 |
| AVEO Pharmaceuticals, Inc. | 1 | $14 |
| Verastem, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
How this compares
Too few hematology-oncology providers in Illinoisto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology-oncology in Carbondale
- Joanna StankiewiczChicago$2K
- Samir UndeviaChicago$2K
- Ann MauerChicago$1K
- Shawn KothariChicago$0
- Brandon BungoChicago$0
- Jane ChurpekChicago$0
- Michael HawkingChicago$0
- Dario VillamarNew Lenox$0
- Megan RandallChicago$0
- Michael KahnWarrenville$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.